TA
ALDX icon

Teachers Advisors’s Aldeyra Therapeutics ALDX Stock Holding History

Teachers Advisors’s Portfolio ALDX Stock Details ALDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$322K Buy
35,641
+9,070
+34% +$77.1K ﹤0.01% 2693
2018
Q4 		$221K Buy
26,571
+7,143
+37% +$73.2K ﹤0.01% 2815
2018
Q3 		$268K Hold
19,428
– – ﹤0.01% 2856
2018
Q2 		$154K Buy
+19,428
New +$155K ﹤0.01% 3026

Other funds holding ALDX

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Teachers Advisors's ALDX Position: Q1 2019 in Review

Teachers Advisors increased its Aldeyra Therapeutics (ALDX) stake by 34% in Q1 2019, buying an estimated $77.1K and bringing the position to 35,641 shares worth $322K. The position accounts for ﹤0.01% of the portfolio, ranked #2693.

Teachers Advisors first reported a position in ALDX in Q2 2018 and has held it in 4 quarters since. 79 funds tracked by Wall St. Rank hold ALDX as of Q1 2019.

  • Teachers Advisors held 35,641 shares of Aldeyra Therapeutics worth $322K as of Q1 2019.
  • Teachers Advisors bought 9,070 Aldeyra Therapeutics shares in Q1 2019, an estimated $77.1K.
  • Aldeyra Therapeutics made up ﹤0.01% of Teachers Advisors's portfolio in Q1 2019, its #2693 holding.
  • Teachers Advisors first reported a position in Aldeyra Therapeutics in Q2 2018 and has held it in 4 quarters since.
  • 79 funds tracked by Wall St. Rank held Aldeyra Therapeutics as of Q1 2019.

Based on Teachers Advisors's 13F filing for Q1 2019, filed 14 May 2019.